Keudell/Morrison Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $365K | Buy |
695
+110
| +19% | +$57.8K | 0.08% | 151 |
|
|
2025
Q1 | $371K | Buy |
585
+36
| +7% | +$22.8K | 0.09% | 139 |
|
|
2024
Q4 | $391K | Buy |
549
+165
| +43% | +$118K | 0.1% | 134 |
|
|
2024
Q3 | $404K | Hold |
384
| – | – | 0.11% | 128 |
|
|
2024
Q2 | $404K | Hold |
384
| – | – | 0.12% | 134 |
|
|
2024
Q1 | $370K | Hold |
384
| – | – | 0.11% | 139 |
|
|
2023
Q4 | $337K | Hold |
384
| – | – | 0.11% | 142 |
|
|
2023
Q3 | $316K | Hold |
384
| – | – | 0.1% | 139 |
|
|
2023
Q2 | $276K | Hold |
384
| – | – | 0.08% | 155 |
|
|
2023
Q1 | $316K | Hold |
384
| – | – | 0.09% | 139 |
|
|
2022
Q4 | $277K | Hold |
384
| – | – | 0.09% | 147 |
|
|
2022
Q3 | $265K | Sell |
384
-30
| -7% | -$20.7K | 0.1% | 146 |
|
|
2022
Q2 | $245K | Sell |
414
-52
| -11% | -$30.8K | 0.09% | 152 |
|
|
2022
Q1 | $325K | Sell |
466
-6
| -1% | -$4.19K | 0.14% | 137 |
|
|
2021
Q4 | $298K | Sell |
472
-115
| -20% | -$72.6K | 0.12% | 139 |
|
|
2021
Q3 | $355K | Sell |
587
-39
| -6% | -$23.6K | 0.15% | 121 |
|
|
2021
Q2 | $350K | Hold |
626
| – | – | 0.19% | 123 |
|
|
2021
Q1 | $296K | Sell |
626
-438
| -41% | -$207K | 0.17% | 129 |
|
|
2020
Q4 | $514K | Sell |
1,064
-5
| -0.5% | -$2.42K | 0.33% | 88 |
|
|
2020
Q3 | $598K | Sell |
1,069
-23
| -2% | -$12.9K | 0.38% | 72 |
|
|
2020
Q2 | $681K | Hold |
1,092
| – | – | 0.56% | 64 |
|
|
2020
Q1 | $533K | Buy |
1,092
+60
| +6% | +$29.3K | 0.52% | 68 |
|
|
2019
Q4 | $387K | Sell |
1,032
-202
| -16% | -$75.8K | 0.27% | 96 |
|
|
2019
Q3 | $342K | Buy |
1,234
+30
| +2% | +$8.31K | 0.28% | 99 |
|
|
2019
Q2 | $364K | Sell |
1,204
-12
| -1% | -$3.63K | 0.32% | 88 |
|
|
2019
Q1 | $499K | Buy |
+1,216
| New | +$499K | 0.44% | 77 |
|